Table I.
Association between miR-144 expression and clinicopathological characteristics.
| miR-144 expression | ||||
|---|---|---|---|---|
| Variable | Cases (n) | Low | High | P-value |
| Age (years) | 0.259 | |||
| <45 | 22 | 14 | 8 | |
| ≥45 | 13 | 11 | 2 | |
| Tumor size | 0.723 | |||
| ≤4 cm | 19 | 13 | 6 | |
| >4 cm | 16 | 12 | 4 | |
| Histological type | 0.661 | |||
| Squamous cell carcinoma | 27 | 20 | 7 | |
| Adenocarcinoma | 8 | 5 | 3 | |
| Histological differentiation | 0.266 | |||
| Well/moderate | 15 | 9 | 6 | |
| Poor | 20 | 16 | 4 | |
| FIGO stage | 0.004a | |||
| IB | 24 | 21 | 3 | |
| >IB | 11 | 4 | 7 | |
| Lymph node metastasis | 0.007a | |||
| No | 26 | 22 | 4 | |
| Yes | 9 | 3 | 6 | |
a
P<0.05. FIGO, International Federation of Gynecology and Obstetrics; miR, microRNA.